Clinical Trial Update: Acthar in Treatment of Refractory Dermatomyositis and Polymyositis [Phase 2]

View source ↗

Summary

Phase 2 trial of Acthar Gel for refractory dermatomyositis and polymyositis has completed, and the results were posted in August 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Rohit Aggarwal, MD | Conditions: Dermatomyositis, Polymyositis | Phase 2 | Status: COMPLETED | Results posted: 2017-08-02